Patent: 10,064,921
✉ Email this page to a colleague
Summary for Patent: 10,064,921
| Title: | Botulinum toxin treatments of neurological and neuropsychiatric disorders |
| Abstract: | Methods for preventing or treating neuropsychiatric disorder and/or a neurological disorder including a neurological disorder mediated by the thalamus. Neuropsychiatric disorders and/or a neurological disorders, including a thalamically mediated disorder can be treated by peripheral administration of a botulinum toxin to or to the vicinity of a trigeminal sensory nerve, thereby preventing or treating a neurological disorder and/or a neuropsychiatric disorder. |
| Inventor(s): | Blumenfeld; Andrew M. (Del Mar, CA) |
| Assignee: | Allergan, Inc. (Irvine, CA) |
| Application Number: | 15/447,770 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,064,921
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2023-10-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
